Summit Global Investments Laboratory Corp Of America Holdings Transaction History

Summit Global Investments

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$197.69 - $227.29 $20,362 - $23,410	-103 Reduced 6.67%	1,441 $327,000
Q3 2023 Oct 13, 2023	SELL	$201.05 - $221.7 $1.04 Million - $1.15 Million	-5,165 Reduced 76.99%	1,544 $310,000
Q2 2023 Jul 18, 2023	SELL	$211.93 - $241.33 $7,417 - $8,446	-35 Reduced 0.52%	6,709 $1.62 Million
Q1 2023 May 04, 2023	BUY	$213.32 - $257.83 $26,025 - $31,455	122 Added 1.84%	6,744 $1.55 Million
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $18,538 - $22,656	-91 Reduced 1.36%	6,622 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $7,168 - $9,176	-35 Reduced 0.52%	6,713 $1.38 Million
Q2 2022 Aug 23, 2022	BUY	$213.86 - $277.87 $25,877 - $33,622	121 Added 1.83%	6,748 $1.58 Million
Q1 2022 Apr 29, 2022	BUY	$259.82 - $298.18 $1.72 Million - $1.98 Million	6,627 New	6,627 $1.75 Million
Q2 2018 Aug 10, 2018	SELL	$160.33 - $189.41 $6.83 Million - $8.06 Million	-42,574 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$161.53 - $178.11 $1.93 Million - $2.13 Million	-11,937 Reduced 21.9%	42,574 $6.89 Million
Q4 2017 Feb 14, 2018	BUY	$147.99 - $163.95 $8.07 Million - $8.94 Million	54,511	54,511 $8.7 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.